Literature DB >> 14722302

Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Pavel Bostik1, Geraldine L Dodd, Francois Villinger, Ann E Mayne, Aftab A Ansari.   

Abstract

CD4(+) T-cell dysfunction highlighted by defects within the intracellular signaling cascade and cell cycle has long been characterized as a direct and/or indirect consequence of human immunodeficiency virus (HIV) infection in humans and simian immunodeficiency virus (SIV) infection in rhesus macaques (RM). Dysregulation of the M phase of the cell cycle is a well-documented effect of HIV or SIV infection both in vivo and in vitro. In this study the effect of SIV infection on the modulation of two important regulators of the M phase-polo-like kinases Plk3 and Plk1-was investigated. We have previously shown that Plk3 is markedly downregulated in CD4(+) T cells from SIV-infected disease-susceptible RM but not SIV-infected disease-resistant sooty mangabeys (SM), denoting an association of downregulation with disease progression. Here we show that, in addition to the downregulation, Plk3 exhibits aberrant activation patterns in the CD4(+) T cells from SIV-infected RM following T-cell receptor stimulation. Interestingly, in vitro SIV infection of CD4(+) T cells leads to the upregulation, rather than downregulation, of Plk3, suggesting that different mechanisms operate in vitro and in vivo. In addition, CD4(+) T cells from RM with high viral loads exhibited consistent and significant upregulation of Plk1, concurrent with an aberrant activation-induced Plk1 response, suggesting complex mechanisms of SIV-induced M-phase abnormalities in vivo. Altogether this study presents a novel mechanism underlying M-phase defects observed in CD4(+) T cells from HIV or SIV-infected disease-susceptible humans and RM which may contribute to aberrant T-cell responses and disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722302      PMCID: PMC321363          DOI: 10.1128/jvi.78.3.1464-1472.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Inverse correlation of telomerase activity/proliferation of CD4+ T lymphocytes and disease progression in simian immunodeficiency virus-infected nonhuman primates.

Authors:  P Bostik; G T Brice; K P Greenberg; A E Mayne; F Villinger; M G Lewis; A A Ansari
Journal:  J Acquir Immune Defic Syndr       Date:  2000-06-01       Impact factor: 3.731

2.  The physical association and phosphorylation of Cdc25C protein phosphatase by Prk.

Authors:  B Ouyang; W Li; H Pan; J Meadows; I Hoffmann; W Dai
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

3.  Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis.

Authors:  G Cannavo'; M Paiardini; D Galati; B Cervasi; M Montroni; G De Vico; D Guetard; M L Bocchino; I Picerno; M Magnani; G Silvestri; G Piedimonte
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

4.  The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.

Authors:  A K Roshak; E A Capper; C Imburgia; J Fornwald; G Scott; L A Marshall
Journal:  Cell Signal       Date:  2000-06       Impact factor: 4.315

5.  Polo-like kinase-1 is a target of the DNA damage checkpoint.

Authors:  V A Smits; R Klompmaker; L Arnaud; G Rijksen; E A Nigg; R H Medema
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

6.  PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer.

Authors:  W Dai; Y Li; B Ouyang; H Pan; P Reissmann; J Li; J Wiest; P Stambrook; J L Gluckman; A Noffsinger; P Bejarano
Journal:  Genes Chromosomes Cancer       Date:  2000-03       Impact factor: 5.006

7.  Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Authors:  K Mori; Y Yasutomi; S Sawada; F Villinger; K Sugama; B Rosenwith; J L Heeney; K Uberla; S Yamazaki; A A Ansari; H Rübsamen-Waigmann
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Cell cycle regulation of the human polo-like kinase (PLK) promoter.

Authors:  T Uchiumi; D L Longo; D K Ferris
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

9.  Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys.

Authors:  P Bostik; A E Mayne; F Villinger; K P Greenberg; J D Powell; A A Ansari
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages.

Authors:  U Holtrich; G Wolf; J Yuan; J Bereiter-Hahn; T Karn; M Weiler; G Kauselmann; M Rehli; R Andreesen; M Kaufmann; D Kuhl; K Strebhardt
Journal:  Oncogene       Date:  2000-10-05       Impact factor: 9.867

View more
  11 in total

1.  Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.

Authors:  Pavel Bostik; Jaruda Kobkitjaroen; Weining Tang; Francois Villinger; Lara E Pereira; Dawn M Little; Susan T Stephenson; Mark Bouzyk; Aftab A Ansari
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

2.  Henipavirus V protein association with Polo-like kinase reveals functional overlap with STAT1 binding and interferon evasion.

Authors:  Louise E Ludlow; Michael K Lo; Jason J Rodriguez; Paul A Rota; Curt M Horvath
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 3.  Understanding the benign nature of SIV infection in natural hosts.

Authors:  Guido Silvestri; Mirko Paiardini; Ivona Pandrea; Michael M Lederman; Donald L Sodora
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

4.  Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS.

Authors:  Damien Vitour; Stéphanie Dabo; Malek Ahmadi Pour; Myriam Vilasco; Pierre-Olivier Vidalain; Yves Jacob; Mariana Mezel-Lemoine; Suzanne Paz; Meztli Arguello; Rongtuan Lin; Frédéric Tangy; John Hiscott; Eliane F Meurs
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

5.  Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.

Authors:  Elizabeth R Sharlow; Stephanie Leimgruber; Tong Ying Shun; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2007-12       Impact factor: 1.738

6.  Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques.

Authors:  Luca Micci; Emily S Ryan; Rémi Fromentin; Steven E Bosinger; Justin L Harper; Tianyu He; Sara Paganini; Kirk A Easley; Ann Chahroudi; Clarisse Benne; Sanjeev Gumber; Colleen S McGary; Kenneth A Rogers; Claire Deleage; Carissa Lucero; Siddappa N Byrareddy; Cristian Apetrei; Jacob D Estes; Jeffrey D Lifson; Michael Piatak; Nicolas Chomont; Francois Villinger; Guido Silvestri; Jason M Brenchley; Mirko Paiardini
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

7.  The HIV-1 gp120/V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific transcriptional signature.

Authors:  Antigone K Morou; Filippos Porichis; Elias Krambovitis; George Sourvinos; Demetrios A Spandidos; Alexandros Zafiropoulos
Journal:  J Transl Med       Date:  2011-09-24       Impact factor: 5.531

8.  Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization.

Authors:  Sharon Lederer; David Favre; Kathie-Anne Walters; Sean Proll; Bittoo Kanwar; Zeljka Kasakow; Carole R Baskin; Robert Palermo; Joseph M McCune; Michael G Katze
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

9.  PLK1 down-regulates parainfluenza virus 5 gene expression.

Authors:  Dengyun Sun; Priya Luthra; Zhuo Li; Biao He
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

10.  Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes.

Authors:  Kathie-Anne Walters; Andrew J Syder; Sharon L Lederer; Deborah L Diamond; Bryan Paeper; Charles M Rice; Michael G Katze
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.